Venus Remedies Limited — Pemetrexed Exporter Profile
Indian Pharmaceutical Exporter · #9 for Pemetrexed · $507.2K export value · DGFT Verified
Venus Remedies Limited is the #9 Indian exporter of Pemetrexed with $507.2K in export value and 42 verified shipments. Venus Remedies Limited holds a 1.8% market share in Pemetrexed exports across 8 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.
Venus Remedies Limited — Pemetrexed Export Profile: Buyers & Destinations
Where Does Venus Remedies Limited Export Pemetrexed?
| Country | Value | Shipments | Share |
|---|---|---|---|
| COLOMBIA | $284.4K | 17 | 56.1% |
| THAILAND | $121.9K | 9 | 24.0% |
| MYANMAR | $46.1K | 8 | 9.1% |
| VENEZUELA | $19.8K | 1 | 3.9% |
| DOMINICAN REPUBLIC | $17.7K | 1 | 3.5% |
| DOMINICAN REPULIC | $13.3K | 1 | 2.6% |
| BOTSWANA | $4.0K | 2 | 0.8% |
| SAUDI ARABIA | $7 | 2 | 0.0% |
| OMAN | $0 | 1 | 0.0% |
Venus Remedies Limited exports Pemetrexed to 9 countries. The largest destination is COLOMBIA accounting for 56.1% of Venus Remedies Limited's Pemetrexed shipments, followed by THAILAND (24.0%) and MYANMAR (9.1%). These destinations reflect Venus Remedies Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Pemetrexed from Venus Remedies Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| ALPHARMA S.A.S. | COLOMBIA | $126.1K | 7 |
| A.S.A.S | COLOMBIA | $61.4K | 4 |
| COSMA MEDICAL CO LIMITED | THAILAND | $56.3K | 4 |
| A S A S | COLOMBIA | $51.2K | 3 |
| A S A S ALPHARMA SASDESCARGUEDIRECTO Y | COLOMBIA | $37.9K | 2 |
| N L N | MYANMAR | $34.6K | 4 |
| P T | DOMINICAN REPUBLIC | $31.0K | 2 |
| C M C L COSMA MEDICAL CO LIMITED | THAILAND | $28.2K | 2 |
| COSMA MEDICAL CO.LTD. | THAILAND | $21.8K | 1 |
| CASA DE REPRESENTACION BC | VENEZUELA | $19.8K | 1 |
Venus Remedies Limited supplies Pemetrexed to 17 buyers globally. The largest buyer is ALPHARMA S.A.S. (COLOMBIA), followed by A.S.A.S (COLOMBIA) and COSMA MEDICAL CO LIMITED (THAILAND). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Pemetrexed Export Value and How Much Does Venus Remedies Limited Contribute?
India exported $20.0M worth of Pemetrexed through 1,209 shipments from 138 suppliers to 92 countries, serving 309 buyers globally. Venus Remedies Limited contributes $507.2K to this total, accounting for 1.8% of India's Pemetrexed exports. Venus Remedies Limited ships Pemetrexed to 9 countries through 17 buyers.
What Is the Average Shipment Value for Venus Remedies Limited's Pemetrexed Exports?
Venus Remedies Limited's average Pemetrexed shipment value is $12.1K per consignment, based on 42 shipments totaling $507.2K. The largest destination is COLOMBIA (56.1% of Venus Remedies Limited's Pemetrexed exports).
How Does Venus Remedies Limited Compare to Other Indian Pemetrexed Exporters?
Venus Remedies Limited ranks #9 among 138 Indian Pemetrexed exporters with a 1.8% market share. The top 3 exporters are FRESENIUS KABI ONCOLOGY LIMITED ($9.0M), EUGIA PHARMA SPECIALITIES LIMITED ($2.4M), SUN PHARMACEUTICAL INDUSTRIES LIMITED ($2.0M). Venus Remedies Limited processed 42 shipments to 8 destination countries.
What Pemetrexed Formulations Does Venus Remedies Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VENPREX 500 MG (PEMETREXED LYOPHILIZED P | $71.3K | 3 |
| VENPREX 100 MG PEMETREXED LYOPHILLIZED POWDER FOR RECONSTITUTION SOLUTION FOR INJECTION 100 MG | $40.3K | 2 |
| VENPREX 500 MG PEMETREXED LYOPHILLIZEDPOWDER FOR RECONSTITUTUIN SOL. FOR INJ.500 MGB.NO.X3IPE022AMD.09/23 ED.08/25 | $24.8K | 1 |
| VENPREX (PEMETREXED LYOPHILIZED POWDER F | $24.5K | 1 |
| PEMETREX-VENUS 500MG PEMETREXED PWR FOR | $21.9K | 1 |
| PEMETREX-VENUS 500MG PEMETREXED POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION500 MG | $21.9K | 1 |
| PEMETREX -VENUS PEMETREXED POWDER FOR CO | $21.8K | 1 |
| PEMETREX-VENUS 500MG PEMETREXED POWDER | $21.6K | 2 |
| PEMETREX-VENUS 500MG PEMETREXED LYOPHILI | $19.8K | 1 |
| PEMETREXED LYOPHILIZED POWDER FOR RECONSTITUTION SOL. FOR INJ. 500 MG.VENPREX 500 MG.B.NO.X4BPE022B,MD.02/24 ED.01/26 | $19.5K | 1 |
Venus Remedies Limited exports 37 distinct Pemetrexed formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VENPREX 500 MG (PEMETREXED LYOPHILIZED P with 3 shipments worth $71.3K.
How Does Venus Remedies Limited Compare to Nearest Pemetrexed Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 6 | INTAS PHARMACEUTICALS LIMITED | $1.4M | 28 | 11 | $49.7K |
| 8 | NAPROD LIFE SCIENCES PRIVATE LIMITED | $812.5K | 32 | 3 | $25.4K |
| 9 | VENUS REMEDIES LIMITED ★ | $507.2K | 42 | 8 | $12.1K |
| 10 | ACCURE LABS PRIVATE LIMITED | $483.0K | 15 | 1 | $32.2K |
| 11 | INTAS PHARMACEUTICALS LTD | $300.0K | 6 | 5 | $50.0K |
Venus Remedies Limited ranks #9 among 138 Indian Pemetrexed exporters. Average shipment value of $12.1K compared to the market average of $145.0K. The closest competitors by value are INTAS PHARMACEUTICALS LIMITED and NAPROD LIFE SCIENCES PRIVATE LIMITED.
Which Indian Ports Ship Pemetrexed Exports?
| Port | Shipments | % Share |
|---|---|---|
| DELHI AIR CARGO ACC (INDEL4) | 209 | 17.3% |
| SAHAR AIR CARGO ACC (INBOM4) | 181 | 15.0% |
| SAHAR AIR | 163 | 13.5% |
| DELHI AIR | 133 | 11.0% |
| CHAWAPAYAL ICD | 43 | 3.6% |
| CHAWAPAYAL ICD (INCPR6) | 41 | 3.4% |
| Bombay Air | 33 | 2.7% |
| HYDERABAD AIR | 32 | 2.6% |
What Other Advanced Oncology Products Does Venus Remedies Limited Export?
Venus Remedies Limited also exports these advanced oncology products. Each links to the detailed product page.
Geopolitical & Trade Policy Impact on Venus Remedies Limited's Pemetrexed Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)
Venus Remedies Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)
These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.
About Venus Remedies Limited
Venus Remedies Limited exports 29 products worth $86.4M. Beyond Pemetrexed, top products include Meropenem, Imipenem, Enoxaparin, Ceftriaxone, Paclitaxel. View the complete Venus Remedies Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Pemetrexed — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Pemetrexed shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 42 individual customs records matching Venus Remedies Limited exporting Pemetrexed, covering 37 formulations to 9 countries via 17 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 92+ countries, 309+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Pemetrexed Export Data from Venus Remedies Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Venus Remedies Limited's Pemetrexed exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Venus Remedies Limited
Full Company Profile →
29 products · $86.4M total trade · 6 categories
Pemetrexed Stats
Company Overview
Top Products by Venus Remedies Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Venus Remedies Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Pemetrexed. For current shipment-level data, contact TransData Nexus.